Investigating social cognition in children with epilepsy
Impact of Executive Functions and Language on Social Cognition in Pediatric Epilepsy
This study is testing how social skills develop in children with epilepsy compared to healthy kids to see if there are any differences.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 96 (estimated) |
| Ages | 6 Years to 12 Years |
| Sex | All |
| Sponsor | CHU de Reims Academic / other |
| Locations | 1 site (Reims) |
| Trial ID | NCT04253379 on ClinicalTrials.gov |
What this trial studies
This study aims to explore the development of social cognition skills in children with epilepsy compared to healthy peers. It will assess the relationship between executive functions, language skills, and social cognition through various evaluations, including neuropsychological assessments. The study will involve children aged 6-12, both with epilepsy and a control group of healthy children, to identify any atypical developments in social cognition among those with epilepsy. Participants will not receive any new treatments but will undergo comprehensive evaluations to gather data.
Who should consider this trial
Good fit: Ideal candidates include children aged 6-12 with a diagnosis of epilepsy who are French native speakers.
Not a fit: Patients with neurological or psychiatric diseases in the control group may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of social cognition development in children with epilepsy, potentially leading to better support and interventions.
How similar studies have performed: While there is existing literature on executive functions and language in children with epilepsy, this specific focus on social cognition is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * exposed children : children aged 6-12 with a diagnosis of epilepsy French native speaker * A control group of age-matched children who meet patient selection criteria with the exception of the epilepsy will also be sought Exclusion Criteria: * neurological or psychiatric disease in control group * Raven's Matrices score \< percentile 10
Where this trial is running
Reims
- Chu Reims — Reims, France (Recruiting)
Study contacts
- Study coordinator: Melanie Jennesson Lyver
- Email: mjennesson-lyver@chu-reims.fr
- Phone: 3 26 78 78 99
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.